Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2017 Nov 7;11(11):CD009197.
doi: 10.1002/14651858.CD009197.pub3.

Periodontal therapy for the management of cardiovascular disease in patients with chronic periodontitis

Chunjie Li  1 , Zongkai Lv, Zongdao Shi, Ye Zhu, Yafei Wu, Longjiang Li, Zipporah Iheozor-Ejiofor
Affiliations

Periodontal therapy for the management of cardiovascular disease in patients with chronic periodontitis

Chunjie Li et al. Cochrane Database Syst Rev. .

Update in

Abstract

Background: There is an association between chronic periodontitis and cardiovascular disease (CVD). However, it is not known whether periodontal therapy could prevent or manage CVD in patients with chronic periodontitis.

Objectives: The objective of this systematic review was to investigate the effects of periodontal therapy in preventing the occurrence of, and management or recurrence of, CVD in patients with chronic periodontitis.

Search methods: Cochrane Oral Health's Information Specialist searched the following databases: Cochrane Oral Health's Trials Register (to 31 August 2017), the Cochrane Central Register of Controlled Trials (CENTRAL) (the Cochrane Library, 2017, Issue 7), MEDLINE Ovid (1946 to 31 August 2017), Embase Ovid (1980 to 31 August 2017) and the Cumulative Index to Nursing and Allied Health Literature (CINAHL EBSCO) (1937 to 31 August 2017) . The US National Institutes of Health Trials Registry (ClinicalTrials.gov), the World Health Organization International Clinical Trials Registry Platform and Open Grey were searched for ongoing trials. No restrictions were placed on the language or date of publication when searching the electronic databases.We also searched the Chinese BioMedical Literature Database (1978 to 27 August 2017), the China National Knowledge Infrastructure (1994 to 27 August 2017), the VIP database (1989 to 27 August 2017) and Sciencepaper Online (2003 to 27 August 2017).

Selection criteria: Randomised controlled trials (RCTs) and quasi-RCTs were considered eligible. Studies were selected if they included patients with a diagnosis of chronic periodontitis and previous CVD (secondary prevention studies) or no CVD (primary prevention studies); patients in the intervention group received active periodontal therapy compared to maintenance therapy, no periodontal treatment or another kind of periodontal treatment in the control group.

Data collection and analysis: Two review authors carried out the study identification, data extraction and risk of bias assessment independently and in duplicate. Any discrepancies between the two authors were resolved by discussion or with a third review author. A formal pilot-tested data extraction form was adopted for the data extraction, and the Cochrane tool for risk of bias assessment was used for the critical appraisal of the literature.

Main results: No studies were identified that assessed primary prevention of CVD in people with periodontitis. One study involving 303 participants with ≥ 50% blockage of one coronary artery or a coronary event within three years, but not the three months prior, was included. The study was at high risk of bias due to deviation from the protocol treatment allocation and lack of follow-up data. The trial compared scaling and root planing (SRP) with community care for a follow-up period of six to 25 months. No data on deaths (all-cause or CVD-related) were reported. There was insufficient evidence to determine the effect of SRP and community care in reducing the risk of CVD recurrence in patients with chronic periodontitis (risk ratio (RR) 0.72; 95% confidence interval (CI) 0.23 to 2.22; very low quality evidence). The effects of SRP compared with community care on high-sensitivity C-reactive protein (hs-CRP) (mean difference (MD) 0.62; -1.45 to 2.69), the number of patients with high hs-CRP (RR 0.77; 95% CI 0.32 to 1.85) and adverse events (RR 9.06; 95% CI 0.49 to 166.82) were also not statistically significant. The study did not assess modifiable cardiovascular risk factors, other blood test results, heart function parameters or revascularisation procedures.

Authors' conclusions: We found very low quality evidence that was insufficient to support or refute whether periodontal therapy can prevent the recurrence of CVD in the long term in patients with chronic periodontitis. No evidence on primary prevention was found.

PubMed Disclaimer

Conflict of interest statement

  1. Chunjie Li was supported by the 2011 Aubrey Sheiham Public Health & Primary Care Scholarship and finished the systematic review at the UK Cochrane Centre. We declare that the scholarship had no impact on the review content.

  2. Zongkai Lv, Zongdao Shi, Ye Zhu, Yafei Wu, Longjiang Li, Zipporah Iheozor‐Ejiofor: no interests to declare.

Figures

Figure 1
Figure 1
Study flow diagram.
Figure 2
Figure 2
Risk of bias summary: review authors' judgements about each risk of bias item for each included study.
Analysis 1.1
Analysis 1.1
Comparison 1 Secondary prevention: periodontal treatment versus community care, Outcome 1 All cardiovascular events (25 months).
Analysis 1.2
Analysis 1.2
Comparison 1 Secondary prevention: periodontal treatment versus community care, Outcome 2 Serum hs‐CRP (1 year).
Analysis 1.3
Analysis 1.3
Comparison 1 Secondary prevention: periodontal treatment versus community care, Outcome 3 Number of participants who had high hs‐CRP (1 year).
Analysis 1.4
Analysis 1.4
Comparison 1 Secondary prevention: periodontal treatment versus community care, Outcome 4 Adverse events related to the treatment (25 months).
See this image and copyright information in PMC

Update of

References

References to studies included in this review

    1. Beck JD, Couper DJ, Falkner KL, Graham SP, Grossi SG, Gunsolley JC, et al. The Periodontitis and Vascular Events (PAVE) pilot study: adverse events. Journal of Periodontology 2008;79(1):90‐6. - PubMed
    2. Couper DJ, Beck JD, Falkner KL, Graham SP, Grossi SG, Gunsolley JC, et al. The Periodontitis and Vascular Events (PAVE) pilot study: recruitment, retention, and community care controls. Journal of Periodontology 2008;79(1):80‐9. - PubMed
    3. Offenbacher S, Beck JD, Moss K, Mendoza L, Paquette DW, Barrow DA, et al. Results from the Periodontitis and Vascular Events (PAVE) Study: a pilot multicentered, randomized, controlled trial to study effects of periodontal therapy in a secondary prevention model of cardiovascular disease. Journal of Periodontology 2009;80(2):190‐201. - PMC - PubMed
    4. Dyke TE, Maupome G, Madden T, Grossi S, Gunsolley JC, Offenbacher S, et al. Periodontal Intervention for Cardiac Events: A Pilot Trial (Periodontitis and Cardiovascular Events or "PAVE"). www.ClinicalTrials.gov2003. [NCT00066053]

References to studies excluded from this review

    1. Amar S. Systemic Endothelial Consequences of Periodontal Disease (Impact of Gum Infection on Heart Disease). www.ClinicalTrials.gov2004. [NCT00093236]
    1. Bokhari SA, Khan AA, Butt AK, Azhar M, Hanif M, Izhar M, et al. Non‐surgical periodontal therapy reduces coronary heart disease risk markers: a randomized controlled trial. Journal of Clinical Periodontology 2012;39(11):1065‐74. - PubMed
    1. Brown DL, Desai KK, Vakili BA, Nouneh C, Lee HM, Golub LM. Clinical and biochemical results of the metalloproteinase inhibition with subantimicrobial doses of doxycycline to prevent acute coronary syndromes (MIDAS) pilot trial. Arteriosclerosis, Thrombosis, and Vascular Biology 2004;24(4):733‐8. - PubMed
    1. Cullinan M, Carle A. The Effect of a Triclosan Containing Dentifrice on the Relationship Between Periodontal Disease and Cardiovascular Disease (Cardiovascular and Periodontal Study: a Randomised Controlled Trial CAPS). www.anzctr.org.au2005. [ACTRN12605000593639]
    1. Cullinan MP, Palmer JE, Carle AD, West MJ, Westerman B, Seymour GJ. The influence of a triclosan toothpaste on adverse events in patients with cardiovascular disease over 5‐years. Sci Total Environ 2015;508:546‐552. - PubMed

References to studies awaiting assessment

    1. Payne JB, Golub LM, Stoner JA, Lee HM, Reinhardt RA, Sorsa T, et al. The effect of subantimicrobial‐dose‐doxycycline periodontal therapy on serum biomarkers of systemic inflammation: a randomized, double‐masked, placebo‐controlled clinical trial. Journal of the American Dental Association 2011;142(3):262‐73. - PMC - PubMed
    2. Payne JB, Stoner JA, Nummikoski PV, Reinhardt RA, Goren AD, Wolff MS, et al. Subantimicrobial dose doxycycline effects on alveolar bone loss in post‐menopausal women. Journal of Clinical Periodontology 2007;34(9):776‐87. - PMC - PubMed
    3. Salminen A, Pussinen PJ, Payne JB, Stoner JA, Jauhiainen M, Golub LM, et al. Subantimicrobial‐dose doxycycline treatment increases serum cholesterol efflux capacity from macrophages. Inflammation Research 2013;62(7):711‐20. - PMC - PubMed

References to ongoing studies

    1. Azhar M, Khan AA, Bokhari SAH. Influence of Periodontal Treatment on Systemic Inflammatory Mediators: hsC‐reactive Protein, Fibrinogen and White Blood Cells in CHD Patients (Influence of Periodontal Treatment on Systemic Inflammatory Mediators Perio‐CHD). www.ClinicalTrials.gov2010. [NCT01201746]
    1. Haas AN. Periodontal Therapy in Coronary Artery Patients (PerioCardio). www.ClinicalTrials.gov2013. [NCT01609725]
    1. Skilton MR, Maple‐Brown LJ, Kapellas K, Celermajer DS, Bartold M, Brown A, et al. The effect of a periodontal intervention on cardiovascular risk markers in Indigenous Australians with periodontal disease: the PerioCardio study. BMC Public Health 2011;11:729. - PMC - PubMed

Additional references

    1. American Academy of Periodontology. International workshop for classification of periodontal diseases and conditions. Annals of Periodontology 1999;4(1):7‐112. - PubMed
    1. Armitage GC. Development of a classification system for periodontal diseases and conditions. Annals of Periodontology 1999;4(1):1‐6. - PubMed
    1. Atkins D, Best D, Briss PA, Eccles M, Falck‐Ytter Y, Flottorp S, et al. Grading quality of evidence and strength of recommendations. BMJ 2004;328(7454):1490. - PMC - PubMed
    1. Austin MA. Epidemiology of hypertriglyceridemia and cardiovascular disease. American Journal of Cardiology 1999;83(9B):13F‐16F. - PubMed
    1. Blum A, Front E, Peleg A. Periodontal care may improve systemic inflammation. Clinical and Investigative Medicine 2007;30(3):E114‐7. - PubMed

Publication types

MeSH terms

LinkOut - more resources